Articles with public access mandates - Susanne SebensLearn more
Not available anywhere: 12
Tumor‐associated macrophages exhibit pro‐and anti‐inflammatory properties by which they impact on pancreatic tumorigenesis
O Helm, J Held‐Feindt, E Grage‐Griebenow, N Reiling, H Ungefroren, ...
International journal of cancer 135 (4), 843-861, 2014
Mandates: German Research Foundation
Diabetes as risk factor for pancreatic cancer: Hyperglycemia promotes epithelial-mesenchymal-transition and stem cell properties in pancreatic ductal epithelial cells
S Rahn, V Zimmermann, F Viol, H Knaack, K Stemmer, L Peters, L Lenk, ...
Cancer letters 415, 129-150, 2018
Mandates: German Research Foundation
Role of myofibroblasts in innate chemoresistance of pancreatic carcinoma—Epigenetic downregulation of caspases
SS Müerköster, V Werbing, D Koch, B Sipos, O Ammerpohl, H Kalthoff, ...
International journal of cancer 123 (8), 1751-1760, 2008
Mandates: German Research Foundation
γδ T cell activation by bispecific antibodies
HH Oberg, C Kellner, D Gonnermann, M Peipp, C Peters, S Sebens, ...
Cellular Immunology 296 (1), 41-49, 2015
Mandates: German Research Foundation
The RGD integrin binding site in human L1-CAM is important for nuclear signaling
D Gast, S Riedle, H Kiefel, SS Müerköster, H Schäfer, MKE Schäfer, ...
Experimental cell research 314 (13), 2411-2418, 2008
Mandates: US National Institutes of Health, German Research Foundation
Metastasis of pancreatic cancer: An uninflamed liver micromilieu controls cell growth and cancer stem cell properties by oxidative phosphorylation in pancreatic ductal …
A Fabian, S Stegner, L Miarka, J Zimmermann, L Lenk, S Rahn, J Buttlar, ...
Cancer letters 453, 95-106, 2019
Mandates: Austrian Science Fund, German Research Foundation
The transcription factor Forkhead box P3 (FoxP3) is expressed in glioma cells and associated with increased apoptosis
J Held-Feindt, K Hattermann, S Sebens, S Krautwald, HM Mehdorn, ...
Experimental cell research 319 (5), 731-739, 2013
Mandates: German Research Foundation
The cancer-associated meprin β variant G32R provides an additional activation site and promotes cancer cell invasion
H Schäffler, W Li, O Helm, S Krüger, C Böger, F Peters, C Röcken, ...
Journal of Cell Science 132 (11), jcs220665, 2019
Mandates: German Research Foundation
Antitumor activity of ALK1 in pancreatic carcinoma cells
H Ungefroren, B Schniewind, S Groth, WB Chen, SS Müerköster, ...
International journal of cancer 120 (8), 1641-1651, 2007
Mandates: German Research Foundation
Negative control of TRAIL-R1 signaling by transforming growth factor β1 in pancreatic tumor cells involves Smad-dependent down regulation of TRAIL-R1
DI Radke, H Ungefroren, O Helm, S Voigt, G Alp, H Braun, S Hübner, ...
Cellular Signalling 28 (11), 1652-1662, 2016
Mandates: German Research Foundation
CRISPR/Cas9-induced knockout reveals the role of ABCB1 in the response to temozolomide, carmustine and lomustine in glioblastoma multiforme
L Radtke, A Majchrzak-Celińska, C Awortwe, I Vater, I Nagel, S Sebens, ...
Pharmacological Research 185, 106510, 2022
Mandates: German Research Foundation
Multimodal targeted nanoparticle-based delivery system for pancreatic tumor imaging in cellular and animal models
OP Medina, RJ Tower, TP Medina, F Ashkenani, L Appold, M Bötcher, ...
Current Pharmaceutical Design 28 (4), 313-323, 2022
Mandates: German Research Foundation
Available somewhere: 87
Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene …
A Arlt, S Sebens, S Krebs, C Geismann, M Grossmann, ML Kruse, ...
Oncogene 32 (40), 4825-4835, 2013
Mandates: German Research Foundation
The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects
K Hattermann, J Held-Feindt, R Lucius, SS Müerköster, MET Penfold, ...
Cancer research 70 (8), 3299-3308, 2010
Mandates: US National Institutes of Health, German Research Foundation
Targeting apoptosis pathways in pancreatic cancer
A Arlt, SS Müerköster, H Schäfer
Cancer letters 332 (2), 346-358, 2013
Mandates: German Research Foundation
Novel bispecific antibodies increase γδ T-cell cytotoxicity against pancreatic cancer cells
HH Oberg, M Peipp, C Kellner, S Sebens, S Krause, D Petrick, ...
Cancer research 74 (5), 1349-1360, 2014
Mandates: German Research Foundation
Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells
S Sebens Müerköster, V Werbing, B Sipos, MA Debus, M Witt, ...
Oncogene 26 (19), 2759-2768, 2007
Mandates: German Research Foundation
Differential roles of Smad2 and Smad3 in the regulation of TGF-β1-mediated growth inhibition and cell migration in pancreatic ductal adenocarcinoma cells: control by Rac1
H Ungefroren, S Groth, S Sebens, H Lehnert, F Gieseler, F Fändrich
Molecular cancer 10, 1-16, 2011
Mandates: German Research Foundation
Cytoprotection “gone astray”: Nrf2 and its role in cancer
C Geismann, A Arlt, S Sebens, H Schäfer
OncoTargets and therapy, 1497-1518, 2014
Mandates: German Research Foundation
EMT-associated up-regulation of L1CAM provides insights into L1CAM-mediated integrin signalling and NF-κB activation
H Kiefel, S Bondong, M Pfeifer, U Schirmer, N Erbe-Hoffmann, H Schäfer, ...
Carcinogenesis 33 (10), 1919-1929, 2012
Mandates: German Research Foundation
Publication and funding information is determined automatically by a computer program